For example, DYRK1B was found to be overexpressed in about 90% of tumour specimens from patients with non-small-cell lung cancer (NSCLC)11, compared to its expression in adjacent lung tissue12,13. This evidence concerns the gene DYRK1B and non-small cell lung carcinoma.